The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?

Haematologica. 2011 Nov;96(11):1575-9. doi: 10.3324/haematol.2011.055392.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Female
  • Germ-Line Mutation*
  • Humans
  • Janus Kinase 2 / genetics*
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / mortality*
  • Male
  • Polymorphism, Single Nucleotide*

Substances

  • JAK2 protein, human
  • Janus Kinase 2